A detailed history of Patriot Investment Management Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Patriot Investment Management Inc. holds 4,522 shares of AZN stock, worth $291,397. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,522
Previous 4,887 7.47%
Holding current value
$291,397
Previous $381,000 7.61%
% of portfolio
0.03%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$76.67 - $87.62 $27,984 - $31,981
-365 Reduced 7.47%
4,522 $352,000
Q2 2024

Jul 15, 2024

SELL
$66.81 - $80.83 $21,045 - $25,461
-315 Reduced 6.06%
4,887 $381,000
Q1 2024

Apr 16, 2024

SELL
$61.03 - $69.57 $25,815 - $29,428
-423 Reduced 7.52%
5,202 $352,000
Q4 2023

Jan 17, 2024

SELL
$61.89 - $69.28 $23,827 - $26,672
-385 Reduced 6.41%
5,625 $378,000
Q3 2023

Oct 17, 2023

SELL
$64.85 - $71.7 $15,823 - $17,494
-244 Reduced 3.9%
6,010 $406,000
Q2 2023

Jul 13, 2023

SELL
$69.91 - $75.81 $22,790 - $24,714
-326 Reduced 4.95%
6,254 $447,000
Q1 2023

Apr 19, 2023

SELL
$63.15 - $71.6 $44,205 - $50,119
-700 Reduced 9.62%
6,580 $456,000
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $102,348 - $132,990
-1,888 Reduced 20.59%
7,280 $493,000
Q3 2022

Nov 02, 2022

SELL
$53.02 - $135.75 $71,046 - $181,905
-1,340 Reduced 12.75%
9,168 $502,000
Q2 2022

Jul 26, 2022

SELL
$59.26 - $71.14 $67,793 - $81,384
-1,144 Reduced 9.82%
10,508 $694,000
Q1 2022

May 02, 2022

SELL
$55.72 - $67.12 $17,273 - $20,807
-310 Reduced 2.59%
11,652 $772,000
Q4 2021

Feb 01, 2022

BUY
$54.02 - $63.83 $22,796 - $26,936
422 Added 3.66%
11,962 $696,000
Q3 2021

Oct 20, 2021

BUY
$55.56 - $60.79 $3,055 - $3,343
55 Added 0.48%
11,540 $693,000
Q2 2021

Aug 12, 2021

SELL
$48.42 - $60.18 $1,694 - $2,106
-35 Reduced 0.3%
11,485 $687,000
Q1 2021

Apr 29, 2021

BUY
$47.16 - $54.44 $45,509 - $52,534
965 Added 9.14%
11,520 $572,000
Q4 2020

Feb 09, 2021

BUY
$48.52 - $58.02 $9,461 - $11,313
195 Added 1.88%
10,555 $527,000
Q3 2020

Oct 23, 2020

BUY
$53.07 - $61.1 $13,798 - $15,886
260 Added 2.57%
10,360 $567,000
Q2 2020

Aug 11, 2020

BUY
$43.1 - $55.31 $18,102 - $23,230
420 Added 4.34%
10,100 $534,000
Q1 2020

May 06, 2020

BUY
$37.79 - $51.33 $365,807 - $496,874
9,680 New
9,680 $432,000
Q4 2019

Feb 10, 2020

SELL
$42.46 - $50.46 $477,038 - $566,918
-11,235 Closed
0 $0
Q3 2019

Oct 30, 2019

SELL
$40.12 - $45.47 $2,808 - $3,182
-70 Reduced 0.62%
11,235 $485,000
Q2 2019

Aug 13, 2019

BUY
$37.28 - $41.68 $6,710 - $7,502
180 Added 1.62%
11,305 $466,000
Q1 2019

May 01, 2019

BUY
$35.49 - $43.02 $394,826 - $478,597
11,125 New
11,125 $449,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Patriot Investment Management Inc. Portfolio

Follow Patriot Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patriot Investment Management Inc. with notifications on news.